ADVANCIS PHARMACEUTICAL CORPORATION EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 10th, 2005 • Advancis Pharmaceutical Corp • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 10th, 2005 Company Industry JurisdictionTHIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made this 4th day of August 2004 by and between Joseph J. Rogus, P.E., a resident of Whitehouse Station, New Jersey (the “Employee”), and Advancis Pharmaceutical Corporation, a corporation organized and existing under the laws of the State of Delaware (the “Company”).
COMMERCIAL SUPPLY AGREEMENTCommercial Supply Agreement • March 10th, 2005 • Advancis Pharmaceutical Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 10th, 2005 Company Industry JurisdictionTHIS COMMERCIAL SUPPLY AGREEMENT (this “Agreement”) is made as of December 3, 2004 (the “Effective Date”), by and between ADVANCIS PHARMACEUTICAL CORPORATION, a Delaware corporation (“Advancis”), and CEPH INTERNATIONAL CORPORATION, a Commonwealth of Puerto Rico corporation (“CEPH”).
AGREEMENT OF SUBLEASEAgreement of Sublease • March 10th, 2005 • Advancis Pharmaceutical Corp • Pharmaceutical preparations • Maryland
Contract Type FiledMarch 10th, 2005 Company Industry JurisdictionTHIS LEASE AGREEMENT, made this 26th day of July, 2000, by and between WESTPHALIA CENTER II LIMITED PARTNERSHIP, a Maryland limited partnership (hereinafter referred to as “Landlord”); and LARGE SCALE PROTEOMICS CORPORATION, a Delaware corporation (hereinafter referred to as “Tenant”).
FIRST AMENDMENT TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • March 10th, 2005 • Advancis Pharmaceutical Corp • Pharmaceutical preparations
Contract Type FiledMarch 10th, 2005 Company IndustryThis Amendment to Development and Commercialization Agreement (this “Amendment”) is made and entered into this Fourteenth day of December, 2004 (the “Effective Date”), by and between Advancis Pharmaceutical Corporation, a Delaware corporation (“Advancis”), and Par Pharmaceutical, Inc., a Delaware corporation (“Par”).